Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,110,300
+$1,349,814 QoQ
Shares Held
117,500
-41.6% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#77
of 205 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Mar 31, 2024CallValue
$3,010,684
CallShares
1,060,100
PutValue
$529,376
PutShares
186,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $50,945,474 across 10 Drug Manufacturers - Specialty & Generic names. AMLX ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
272,085 | $22,523,196 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
188,381 | $6,531,169 | |
| 3 | HROW |
Harrow, Inc.
|
135,775 | $5,766,364 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
200,000 | $4,902,000 | |
| 5 | CRDL |
Cardiol Therapeutics Inc.
|
3,325,000 | $3,524,500 | |
| 6 | CPIX |
Cumberland Pharmaceuticals Inc
|
503,153 | $3,260,431 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
117,500 | $2,110,300 | |
| 8 | DERM |
Journey Medical Corp
|
251,436 | $1,780,166 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,110,300 | 117,500 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $760,486 | 201,187 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $889,545 | 274,551 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $521,646 | 274,551 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,010,684 | 1,060,100 | Call | Sole | 2024-05-17 | |
| 2024-03-31 | $941,320 | 331,451 | Shares | Sole | 2024-05-17 | |
| 2024-03-31 | $529,376 | 186,400 | Put | Sole | 2024-05-17 | |
| 2023-12-31 | $12,916,800 | 877,500 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $19,112,448 | 1,298,400 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $37,810 | 2,065 | Call | Sole | 2023-11-14 | |
| 2023-03-31 | $4,401,000 | 150,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $293,400 | 10,000 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $7,037,500 | 250,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $6,756,408 | 350,800 | Call | Sole | 2022-08-12 | |
| 2022-06-30 | $4,748,630 | 246,554 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,212,500 | 250,000 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $5,097,003 | 396,654 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||